ARIMIDEX (1MG) (50 TABLETS)

Selective Non-Steroidal Aromatase Inhibitor | Estrogen Control, Gynecomastia Prevention & Fluid Balance

Overview:
Arimidex (Anastrozole) is a potent, highly selective non-steroidal aromatase inhibitor (AI) engineered to regulate systemic estrogen levels. By competitively binding to the aromatase enzyme, Anastrozole blocks the peripheral conversion of circulating androgens into estrogens (specifically estradiol). This prevents excess estrogenic side effects, reduces subcutaneous fluid retention, and protects against gynecomastia during androgenic research cycles.

This product is supplied as a secure pack containing 50 oral tablets, with each tablet accurately dosed at 1mg of active Anastrozole.

Elevated estradiol levels during high-androgen protocols can lead to unwanted water weight, elevated blood pressure, mood fluctuations, and tissue swelling in the chest. Unlike Selective Estrogen Receptor Modulators (SERMs) that merely block receptors at specific tissue sites, Anastrozole directly inhibits the aromatase enzyme itself, reducing baseline serum estrogen concentrations by up to 80%.

The 1mg tablet strength allows for easy, flexible administration schedules (e.g., full, half, or quarter tablet dosing) to precisely dial in target serum estradiol levels without over-suppressing estrogen. Having 50 tablets provides an extended, highly cost-effective supply for multiple research cycles or long-term maintenance.

• Potent Aromatase Inhibition: Directly suppresses the enzymatic conversion of test-based compounds into estradiol (E2).
• Gynecomastia Prevention: Blocks estrogenic stimulation of breast tissue, preventing swelling and tenderness.
• Fluid & Blood Pressure Control: Reduces subcutaneous water retention to maintain a dry cosmetic physique and support vascular health.
• HPTA & Testosterone Support: Helps maintain healthy LH and FSH signaling by preventing excessive negative feedback from elevated estrogen.
• Precise 1mg Tablets: Easily split for flexible micro-dosing protocols tailored to individual aromatization rates.

• Half-Life & Timing: Anastrozole has an active terminal elimination half-life of approximately 40 to 50 hours. It is typically administered every other day (EOD) or 2–3 times weekly with food to maintain steady blood levels.
• Dose Calibration: Protocol requirements vary widely based on total androgen load; starting with lower doses (e.g., 0.25mg to 0.5mg EOD) and adjusting based on blood work is standard practice.
• Swallowing: Swallow tablets whole with water. Do not crush or chew.

• Avoid Over-Suppression: Estrogen is vital for joint health, bone density, lipid control, and brain function. Completely crashing estradiol levels should be avoided.
• Lipid & Bone Health: Prolonged estrogen suppression can impact HDL/LDL ratios and bone mineral density; regular blood work is strongly recommended.
• Blood Work Integration: Always baseline and monitor serum Estradiol (E2), total testosterone, and lipid panels throughout active protocols.